Cliniweave antimicrobial technology could reduce spread of MRSA
An antimicrobial technology which can be integrated into everything found within the hospital setting (including bedside tables, light switches and even air conditioning filters) could dramatically reduce the spread of MRSA, according to new research.??
The technology, called Cliniweave, has been studied at Imperial College, London by microbiologist Professor Mark Enright, who compared its effectiveness against three silver-based antimicrobial fabrics in reducing the bacteria associated with MRSA. The results showed that only Cliniweave-treated samples demonstrated significant antibacterial activity against high concentrations of MRSA, severely reducing bacterial numbers within just one hour.
Enright added: “Our research indicates that Cliniweave is potently antibacterial; not only did it prove effective but it was also extremely fast acting. It is effective against hospital pathogens including MRSA, C. Difficile and E. coli. Trials are underway to test efficacy against other agents such as anthrax and SARS.’
George Costa, md of IFT, the manufacturer of Cliniweave, added: “After nearly five years of research and testing Cliniweave is now ready for market. The result of the testing at Imperial College means that our unique technology can ensure a major breakthrough in the battle against hospital acquired infections.”
??Cliniweave employs a triple attack against bacteria by disrupting membrane transport function (metal chelation), inhibiting ATP synthesis, and disrupting the cell wall coupling enzyme. This ensures rapid death of bacteria and does not promote bacterial resistance.
The environmentally friendly active ingredient that provides Cliniweave’s antimicrobial performance exceeds British Standards wash durability testing and meets the safety requirements of the European Commission.